{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:35:02Z","timestamp":1792118102155,"version":"4.4.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41579-026-01286-y","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:10:28Z","timestamp":1773234628000},"page":"305-307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Reverse vaccinology 3.0"],"prefix":"10.1038","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-5788","authenticated-orcid":false,"given":"Emanuele","family":"Andreano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-542X","authenticated-orcid":false,"given":"Jason S.","family":"McLellan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rino","family":"Rappuoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"key":"1286_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S1369-5274(00)00119-3","volume":"3","author":"R Rappuoli","year":"2000","unstructured":"Rappuoli, R. Reverse vaccinology. Curr. Opin. Microbiol. 3, 445\u2013450 (2000).","journal-title":"Curr. Opin. Microbiol."},{"key":"1286_CR2","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1084\/jem.20151960","volume":"213","author":"R Rappuoli","year":"2016","unstructured":"Rappuoli, R., Bottomley, M. J., D\u2019Oro, U., Finco, O. & De Gregorio, E. Reverse vaccinology 2.0: human immunology instructs vaccine antigen design. J. Exp. Med. 213, 469\u2013481 (2016).","journal-title":"J. Exp. Med."},{"key":"1286_CR3","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1126\/science.1234914","volume":"340","author":"JS McLellan","year":"2013","unstructured":"McLellan, J. S. et al. Structure of RSV fusion glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Science 340, 1113\u20131117 (2013).","journal-title":"Science"},{"key":"1286_CR4","doi-asserted-by":"publisher","first-page":"eaeb3840","DOI":"10.1126\/scitranslmed.aeb3840","volume":"17","author":"I Paciello","year":"2025","unstructured":"Paciello, I. et al. Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153. Sci. Transl. Med. 17, eaeb3840 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1286_CR5","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.abf6840","volume":"371","author":"AA Cohen","year":"2021","unstructured":"Cohen, A. A. et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science 371, 735\u2013741 (2021).","journal-title":"Science"},{"key":"1286_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","volume":"620","author":"JL Watson","year":"2023","unstructured":"Watson, J. L. et al. De novo design of protein structure and function with RFdiffusion. Nature 620, 1089\u20131100 (2023).","journal-title":"Nature"},{"key":"1286_CR7","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41586-024-07385-1","volume":"629","author":"TA Desautels","year":"2024","unstructured":"Desautels, T. A. et al. Computationally restoring the potency of a clinical antibody against Omicron. Nature 629, 878\u2013885 (2024).","journal-title":"Nature"},{"key":"1286_CR8","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1126\/science.abd7331","volume":"371","author":"B Hie","year":"2021","unstructured":"Hie, B., Zhong, E. D., Berger, B. & Bryson, B. Learning the language of viral evolution and escape. Science 371, 284\u2013288 (2021).","journal-title":"Science"},{"key":"1286_CR9","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","volume":"359","author":"CH June","year":"2018","unstructured":"June, C. H., O\u2019Connor, R. S., Kawalekar, O. U., Ghassemi, S. & Milone, M. C. CAR T cell immunotherapy for human cancer. Science 359, 1361\u20131365 (2018).","journal-title":"Science"},{"key":"1286_CR10","doi-asserted-by":"publisher","first-page":"eadd6502","DOI":"10.1126\/science.add6502","volume":"378","author":"DJ Leggat","year":"2022","unstructured":"Leggat, D. J. et al. Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science 378, eadd6502 (2022).","journal-title":"Science"}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01286-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01286-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T12:02:06Z","timestamp":1776427326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41579-026-01286-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1286"],"URL":"https:\/\/doi.org\/10.1038\/s41579-026-01286-y","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"11 March 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.R. holds shares in Novartis and GSK group of companies. E.A. and R.R. are inventors on Italian patent application no. 102024000030036 (Human monoclonal antibodies against Monkeypox and other Orthopoxviruses) filed on 27 December 2024. E.A., J.S.M. and R.R. are inventors on US patent application no. 63\/802,899 filed on 9 May 2025 (Monkeypox virus OPG153 globular domain vaccine).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}